Table 2:
Overall | AAV | IgG4-RD | SSc | P-Value | |
---|---|---|---|---|---|
N | 132 | 41 | 61 | 30 | |
MUIS n (%) | |||||
Median, IQR | 55.0 [48.0, 62.0] | 55.0 [48.0, 62.0] | 53.0 [48.0, 58.0] | 59.0 [55.0, 66.0] | 0.002 |
Q1 (22–44) | 21 (15.9) | 8 (19.5) | 12 (19.7) | 1 (3.3) | |
Q2 (44–66) | 97 (73.5) | 25 (61.0) | 48 (78.7) | 24 (80.0) | |
Q3 (66–88) | 13 (9.8) | 7 (17.1) | 1 (1.6) | 5 (16.7) | |
Q4 (88–110) | 1 (0.8) | 1 (2.4) | 0 (0.0) | 0 (0.0) | |
Missing | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
PHQ-8 n (%) | |||||
Median, IQR | 3.0 [1.0, 6.0] | 4.0 [2.0, 9.0] | 2.5 [0.5, 5.0] | 3.0 [1.0, 7.0] | 0.03 |
Minimal (0–4) | 84 (63.6) | 21 (51.2) | 44 (72.1) | 19 (63.3) | 0.10* |
Mild (5–9) | 31 (23.5) | 10 (24.4) | 13 (21.3) | 8 (26.7) | |
Moderate (10–14) | 5 (3.8) | 4 (9.8) | 0 (0.0) | 1 (3.4) | |
Moderately Severe (15–19) | 5 (3.8) | 2 (4.9) | 2 (3.3) | 1 (3.4) | |
Severe (20–24) | 5 (3.8) | 4 (9.8) | 1 (1.6) | 0 (0.0) | |
Missing | 2 (1.5) | 0 (0.0) | 1 (1.6) | 1 (3.4) | |
GAD-7 n (%) | |||||
Median, IQR | 2.0 [0.0, 5.5] | 5.0 [2.0, 8.0] | 1.0 [0.0, 4.0] | 2.0 [0.0, 5.0] | 0.002 |
Minimal (0–4) | 90 (68.2) | 20 (48.8) | 48 (78.7) | 22 (73.3) | 0.005* |
Mild (5–9) | 34 (25.8) | 16 (39.0) | 11 (18.0) | 7 (23.3) | |
Moderate (10–14) | 6 (4.5) | 4 (9.8) | 1 (1.6) | 1 (3.3) | |
Severe (15–21) | 2 (1.5) | 1 (2.4) | 1 (1.6) | 0 (0.0) | |
Missing | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
SIP n (%) | |||||
Median, IQR | 1.0 [0.0, 6.0] | 2.0 [0.0, 6.0] | 1.0 [0.0, 7.0] | 1.0 [0.0, 5.0] | 0.60 |
Q1 (0–5) | 92 (69.7) | 27 (65.9) | 41 (67.2) | 24 (80.0) | |
Q2 (6–11) | 34 (25.8) | 12 (29.3) | 16 (26.2) | 6 (20.0) | |
Q3 (12–16) | 6 (4.5) | 2 (4.9) | 4 (6.6) | 0 (0.0) | |
Q4 (17–22) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
Missing | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
AAV: ANCA-Associated Vasculitis; IgG4-RD: IgG4-Related Disease; SSc: Systemic Sclerosis; MUIS: Mishel Uncertainty in Illness Scale; PHQ-8: Patient Health Questionnaire depression scale; GAD-7: General Anxiety Disorder; SIP: Sickness Impact Profile
P-value compares the proportion of patients with at least mild depression or anxiety across the three disease groups.